2026 -- S 2459 | |
======== | |
LC004727 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2026 | |
____________ | |
A N A C T | |
RELATING TO HEALTH AND SAFETY -- RHODE ISLAND BAN ON THE CORPORATE | |
PRACTICE OF MEDICINE ACT | |
| |
Introduced By: Senators Ujifusa, Mack, DiMario, Lauria, Valverde, Kallman, Acosta, | |
Date Introduced: February 06, 2026 | |
Referred To: Senate Health & Human Services | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Title 23 of the General Laws entitled "HEALTH AND SAFETY" is hereby |
2 | amended by adding thereto the following chapters: |
3 | CHAPTER 106 |
4 | RHODE ISLAND BAN ON THE CORPORATE PRACTICE OF MEDICINE ACT |
5 | 23-106-1. Prohibition on the corporate practice of Medicine (“CPOM”). |
6 | (a) Except as provided in § 23-106-2(b), it is unlawful for an individual, corporation, |
7 | partnership, or any other entity without proper licensure pursuant to the provisions of title 23 |
8 | (“health and safety”), to own a medical practice, employ healthcare licensees, or otherwise engage |
9 | in the practice of medicine. |
10 | (b) Notwithstanding the foregoing, an individual, corporation, partnership, or any other |
11 | entity, without a license under this title or chapter 37 of title 5 that is permitted to employ licensees |
12 | under § 23-106-2 shall not indirectly or directly interfere with, control, or otherwise direct the |
13 | professional judgment or clinical decisions of a licensee. |
14 | 23-106-2. Corporate entities permitted to employ physicians. |
15 | (a) A medical practice organized for the purpose of practicing medicine may employ |
16 | physicians and engage in the practice of medicine under the following conditions: |
17 | (1) Licensees who are licensed in this state to practice medicine shall hold the majority of |
18 | each class of shares that are entitled to vote.; |
| |
1 | (2) Licensees who are licensed in this state to practice medicine shall be a majority of the |
2 | directors.; and |
3 | (3) All officers except the secretary and treasurer, if any, must be licensees who are licensed |
4 | in this state to practice medicine. The same person may hold any two (2) or more offices. |
5 | (b) The following entities may employ physicians and engage in the practice of medicine: |
6 | (1) Safety net clinics and public healthcare providers, including federally qualified health |
7 | centers, rural health clinics; |
8 | (2) Public hospitals; |
9 | (3) Health and hospital districts; |
10 | (4) School-based health clinics; and |
11 | (5) Tribal health clinics. |
12 | 23-106-3. Regulating contracts between medical practices and management services |
13 | organizations. |
14 | (a) Ban on straw ownership. |
15 | (1) Licensee owners of a medical practice shall exhibit meaningful ownership of the |
16 | medical practice. |
17 | (2) Meaningful ownership shall require that each licensee owner is duly licensed and |
18 | present in the state and substantially engaged in delivering medical care or managing the medical |
19 | practice. |
20 | (b) Ban on dual ownership or interests. |
21 | (1) A shareholder, director, or officer of a medical practice shall not: |
22 | (i) Own or control shares in, serve as a director or officer of, be an employee of or an |
23 | independent contractor with, or otherwise participate in managing both the medical practice and a |
24 | management services organization with which the medical practice has a contract; or |
25 | (ii) Receive substantial compensation or remuneration from a management services |
26 | organization in return for ownership or management of the medical practice. |
27 | (iii) Subsection (b)(1)(i) of this section shall not apply to the shareholders, directors, or |
28 | officers of a medical practice if the medical practice owns a majority of the interest in the |
29 | management services organization or separate legal entity. |
30 | (c) Ban on stock transfer restriction agreements. |
31 | (1) A medical practice shall not transfer or relinquish control over the sale, the restriction |
32 | of the sale, or the encumbrance of the sale of the medical practice’s shares or assets. |
33 | (2) A medical practice shall not transfer or relinquish control over the issuing of shares of |
34 | stock in the medical practice, in a subsidiary of the medical practice or an entity affiliated with the |
| LC004727 - Page 2 of 11 |
1 | medical practice, or the paying of dividends. |
2 | (d) Ban on restrictive covenants. |
3 | (1) Noncompetition agreements: |
4 | (i) Except as provided in subsection (d)(1)(ii) of this section, a noncompetition agreement |
5 | between a licensee and another person is void and unenforceable. |
6 | (ii) A noncompetition agreement between a licensee and another person is valid and |
7 | enforceable if the licensee is a shareholder or member of the other person or otherwise owns or |
8 | controls an ownership or membership interest that is equivalent to twenty-five percent (25%) or |
9 | more of the entire ownership or membership interest that exists in the other person. |
10 | (2) Non-disclosure and nondisparagement agreements; |
11 | (i) A nondisclosure agreement or nondisparagement agreement between a licensee and a |
12 | management services organization is void and unenforceable; |
13 | (ii) The provisions of subsection (d)(2)(i) shall not limit or otherwise affect any cause of |
14 | action that: |
15 | (A) A party to, or third-party beneficiary of, the agreement may have with respect to a |
16 | statement of a licensee that constitutes libel, slander, a tortious interference with contractual |
17 | relations, or another tort for which the party has a cause of action against the licensee; and |
18 | (B) Does not depend upon or derive from a breach or violation of an agreement described |
19 | in this subsection. |
20 | (e) Ban on advertising. It is unlawful for a management services organization or other legal |
21 | entity that is not the medical practice to advertise the medical practice’s services under the name |
22 | of the entity that is not the medical practice. |
23 | (f) Ban on relinquishing control of the medical practice. |
24 | (1) A medical practice shall not by means of a contract or other agreement or arrangement, |
25 | by providing in the medical practice’s articles of incorporation or bylaws, by forming a subsidiary |
26 | or affiliated entity or by other means, relinquish control over or otherwise transfer de facto control |
27 | over any of the medical practice’s administrative, business or clinical operations that may affect |
28 | clinical decision-making or the nature or quality of medical care that the medical practice delivers. |
29 | (2) Conduct prohibited under subsection (f)(1) of this section includes, but is not limited |
30 | to, relinquishing ultimate decision-making authority over: |
31 | (i) Hiring or terminating, setting work schedules and compensation, or otherwise |
32 | specifying terms of employment of employees who are licensed to practice medicine in this state |
33 | or who are licensed in this state as physician assistants or nurse practitioners; |
34 | (ii) The disbursement of revenue generated from physician fees and other revenue |
| LC004727 - Page 3 of 11 |
1 | generated by physician services. |
2 | (iii) Collaboration and negotiation with hospitals and other institutions in which the |
3 | licensees of the medical practice may deliver clinical care, particularly with regard to controlling |
4 | licensee schedules as a means of discipline. |
5 | (iv) Setting staffing levels, or specifying the period of time a licensee may see a patient, |
6 | for any location that serves patients; |
7 | (v) Making diagnostic coding decisions; |
8 | (vi) Setting clinical standards or policies; |
9 | (vii) Setting policies for patient, client, or customer billing and collection; |
10 | (viii) Setting the prices, rates, or amounts the medical practice charges for a licensee’s |
11 | services; or |
12 | (ix) Negotiating, executing, performing, enforcing, or terminating contracts with third- |
13 | party payors or persons that are not employees of the medical practice. |
14 | (4) The conduct described in subsection (f)(1) and (f)(2) of this subsection shall not prohibit |
15 | collection of quality metrics as required by law or in accordance with an agreement to which the |
16 | medical practice is a party or setting criteria for reimbursement under a contract between the |
17 | medical practice and an insurer or payer or entity that otherwise reimburses the medical practice |
18 | for medical care. |
19 | (5) Notwithstanding the provisions of subsection (f)(1) of this subsection, a medical |
20 | practice may delegate administrative, business, or clinical operations described in subsection (f)(2) |
21 | of this section to a managed services organization; provided that, the medical practice’s shareholder |
22 | agreement bestows this delegation authority exclusively to the majority of shareholders who are |
23 | licensee-owners, and such delegation does not relinquish de facto control of the medical practice |
24 | to non-licensees. |
25 | 23-106-4. Protections for employed licensees. |
26 | (a) The following provisions apply to persons licensed pursuant to the provisions of this |
27 | title or chapter 37 of title 5 to provide healthcare services and who are employed by, or who provide |
28 | healthcare services under contract with, an unlicensed person, corporation, or other entity under |
29 | this chapter. |
30 | (b) Ban on restrictive covenants. |
31 | (1) Noncompetition agreements. A nondisclosure agreement or nondisparagement |
32 | agreement between a licensee and an employer or another entity is void and unenforceable. |
33 | (2) Non-disclosure and nondisparagement agreements. |
34 | (i) A nondisclosure agreement or nondisparagement agreement between a licensee and an |
| LC004727 - Page 4 of 11 |
1 | employer or any other entity is void and unenforceable. |
2 | (ii) Subsection (b)(2) of this section shall not limit or otherwise affect any cause of action |
3 | that: |
4 | (A) A party to, or third-party beneficiary of, the agreement may have with respect to a |
5 | statement of a licensee that constitutes libel, slander, a tortious interference with contractual |
6 | relations, or another tort for which the party has a cause of action against the licensee; and |
7 | (B) Does not depend upon or derive from a breach or violation of an agreement described |
8 | in subsection (b)(2)(ii)(A) of this section. |
9 | (c) Ban on interfering with, controlling, or otherwise directing the professional judgment |
10 | or clinical decisions of a licensee. Conduct prohibited pursuant to the provisions of this section |
11 | includes, but is not limited to, controlling, either directly or indirectly, through discipline, |
12 | punishment, threats, adverse employment actions, coercion, retaliation, or excessive pressure, the |
13 | following: |
14 | (1) The period of time a licensee may spend with a patient, including the time permitted |
15 | for a licensee to triage patients in the emergency department or evaluate admitted patients; |
16 | (2) The period of time within which a licensee shall discharge a patient; |
17 | (3) The clinical status of the patient, including whether the patient should be admitted to |
18 | inpatient status, whether the patient should be kept in observation status, whether the patient should |
19 | receive palliative care, and whether and where the patient should be referred upon discharge, such |
20 | as a skilled nursing facility; |
21 | (4) The diagnoses, diagnostic terminology, or codes that are entered into the medical record |
22 | by the licensee; |
23 | (5) The range of clinical orders available to licensees, including by configuring the medical |
24 | record to prohibit or significantly limit the options available to the licensee; and |
25 | (6) Any other action specified by regulation to constitute impermissible interference or |
26 | control over the clinical judgment and decision-making of a licensee. |
27 | 23-106-5. Enforcement. |
28 | (a) Attorney general enforcement authority. |
29 | (1) The attorney general may subpoena any records necessary to enforce any provisions of |
30 | this chapter or to investigate suspected violations of any provisions of this chapter or any conditions |
31 | imposed by conditional approval pursuant to the material transactions review process. |
32 | (2) The attorney general may enforce any requirement of this chapter and any conditions |
33 | imposed by a conditional approval pursuant to the material transactions review process to the fullest |
34 | extent provided by law, including damages. In addition to any legal remedies the attorney general |
| LC004727 - Page 5 of 11 |
1 | may have, the attorney general shall be entitled to specific performance, injunctive relief, and other |
2 | equitable remedies a court deems appropriate for any violations or imminent violation of any |
3 | requirement of this chapter or any violations or breach of any of the conditions and shall be entitled |
4 | to recover its attorneys’ fees and costs incurred in remedying each violation. |
5 | (3) The attorney general may also impose a statutory penalty of ten thousand dollars |
6 | ($10,000) per day for any violation of this chapter or of any conditions imposed pursuant to a |
7 | conditional approval and may rescind or deny approval for any other past, pending, or future |
8 | material change transactions involving the healthcare entity or an affiliate. |
9 | (4) Nothing in this section shall narrow, abrogate, or otherwise alter the authority of the |
10 | attorney general to prosecute violations of antitrust or consumer protection requirements. |
11 | (b) Administrative enforcement. |
12 | (1) Any entity that violates any provision of this chapter or any rules adopted pursuant |
13 | thereto shall be subject to an administrative penalty of ten thousand dollars ($10,000) per day for |
14 | any violation; |
15 | (2) The department of health engaged in market oversight may disapprove any transaction |
16 | or agreement that violates this chapter; and |
17 | (3) The department of health may refer any entity to the attorney general to review for |
18 | enforcement of any noncompliance with this chapter or regulations adopted pursuant thereto. |
19 | (c) Private right of action. |
20 | (1) Any person aggrieved by a violation of this statute may file suit in any superior court |
21 | in the state without regard to exhaustion of any alternative administrative remedies provided herein. |
22 | (2) Upon application by a complainant and in such circumstances as the court may deem |
23 | just, the court may appoint an attorney for such complainant and may authorize the commencement |
24 | of the action. |
25 | (3) If the court finds that the respondent has intentionally violated any provision of this |
26 | chapter or any regulation under this chapter, it may award damages up to and including an amount |
27 | equal to the amount of actual damages, or statutory damages of up to one hundred thousand dollars |
28 | ($100,000) per plaintiff per violation, or other equitable relief. |
29 | (4) Any civil action brought under this section shall be subject to appeal. |
30 | (d) The attorney general and the department of health may adopt rules and regulations as |
31 | necessary to implement the provisions of this chapter. |
32 | CHAPTER 107 |
33 | RHODE ISLAND TRANSPARENCY IN OWNERSHIP AND CONTROL OF HEALTHCARE |
34 | ENTITIES |
| LC004727 - Page 6 of 11 |
1 | 23-107-1. Reporting of ownership and control of healthcare entities. |
2 | (a) Each healthcare entity shall report to the department of health, on or before January 1, |
3 | 2027, and on or before January 1 annually thereafter, upon the consummation of a material change |
4 | transaction involving the entity as described in chapter 106 of title 23, in a form and manner |
5 | required by the department of health, with the following information: |
6 | (1) Legal name of entity; |
7 | (2) Business address of healthcare entity; |
8 | (3) Locations of operations; |
9 | (4) Business identification numbers of the entity, as applicable, including: |
10 | (i) Taxpayer identification number (TIN); |
11 | (ii) National provider identifier (NPI); |
12 | (iii) Employer identification number (EIN); |
13 | (iv) CMS certification number (CCN); |
14 | (v) National Association of Insurance Commissioners (NAIC) identification number; |
15 | (vi) A personal identification number associated with a license issued by the department of |
16 | insurance; and |
17 | (vii) Pharmacy benefit manager identification number associated with a license or |
18 | registration of the pharmacy benefit manager in this state. |
19 | (5) Name and contact information of a representative of the healthcare entity; |
20 | (6) The name, business address, and business identification numbers listed in subsection |
21 | (a)(4) of this section for each person or entity that, with respect to the relevant healthcare entity: |
22 | (i) Has an ownership or investment interest; |
23 | (ii) Has a controlling interest; |
24 | (iii) Is a management services organization; or |
25 | (iv) Is a significant equity investor; |
26 | (7) A current organizational chart showing the business structure of the healthcare entity, |
27 | including: |
28 | (i) Any entity listed in this section; |
29 | (ii) Affiliates, including entities that control or are under common control as the healthcare |
30 | entity; and |
31 | (iii) Subsidiaries. |
32 | (8) For a healthcare entity that is a provider organization or a healthcare facility: |
33 | (i) The affiliated healthcare providers identified by name, license type, specialty, NPI, and |
34 | other applicable Identification number listed in subsection (a)(4) of this section; the address of |
| LC004727 - Page 7 of 11 |
1 | principal practice location; and whether the healthcare provider is employed or contracted by the |
2 | entity; and |
3 | (ii) The name and address of affiliated healthcare facilities by license number, license type, |
4 | and capacity in each major service area. |
5 | (8) The names, NPI (if applicable), and compensation of the members of the governing |
6 | board, board of directors, or similar governance body for the healthcare entity; any entity that is |
7 | owned or controlled by, affiliated with, under common control as the healthcare entity, and any |
8 | entity listed in subsection (a)(5) of this section; and |
9 | (9) Comprehensive financial reports of the healthcare entity and any ownership and control |
10 | entities, including audited financial statements, cost reports, annual costs, annual receipts, realized |
11 | capital gains and losses, accumulated surplus, and accumulated reserves. |
12 | 23-107-2. Exemptions. |
13 | The following healthcare entities are exempt from the reporting requirements under § 23- |
14 | 107-1: |
15 | (1) A healthcare entity that is an independent provider organization, without any ownership |
16 | or control entities, consisting of two (2) or fewer physicians; provided, however, that if such |
17 | healthcare entity experiences a material change transaction under the provisions of chapter 106 of |
18 | title 23, the healthcare entity is subject to reporting under upon the consummation of the transaction. |
19 | (2) A healthcare provider or provider organization that is owned or controlled by another |
20 | healthcare entity, if the healthcare provider organization is shown in the organizational chart |
21 | submitted under § 23-107-1, and the controlling healthcare entity reports all the information |
22 | required under § 23-107-1 on behalf of the controlled or owned entity; provided, however, that |
23 | healthcare facilities are not subject to this exemption. |
24 | 23-107-3. Regulatory authorization. |
25 | (a) The department of health shall promulgate rules and regulations necessary to implement |
26 | the provisions of this chapter, specify the format and content of reports, and impose penalties for |
27 | non-compliance. The department of health may require additional reporting of data or information |
28 | that it determines is necessary to better protect the public’s interest in monitoring the financial |
29 | conditions, organizational structure, business practices, and market share of each registered |
30 | healthcare entity. |
31 | (b) The department of health may assess administrative fees on healthcare entities in an |
32 | amount to help defray the costs in overseeing and implementing the provisions of this chapter. |
33 | 23-107-4. Sharing of ownership information to improve transparency. |
34 | (a) Information provided pursuant to the provisions of this chapter to be posted pursuant to |
| LC004727 - Page 8 of 11 |
1 | subsection (b) of this section shall be public information and shall not be considered confidential, |
2 | proprietary, or a trade secret; provided, however, that any individual healthcare provider’s taxpayer |
3 | ID that is also their social security number shall be confidential. |
4 | (b) Not later than January 1, 2027, and annually on or before January 1 thereafter, the |
5 | department of health shall post on a publicly available website a report with respect to the previous |
6 | one year period, including: |
7 | (1) The number of healthcare entities reporting for such year, disaggregated by the business |
8 | structure of each specified entity; |
9 | (2) The names, addresses, business structure of any entities with an ownership or |
10 | controlling interest in each healthcare entity; |
11 | (3) Any change in ownership or control for each healthcare entity; |
12 | (4) Any change in the tax identification number of a healthcare entity; |
13 | (5) As applicable, the name, address, tax identification number, and business structure of |
14 | other affiliates under common control, subsidiaries, and management services entities of the |
15 | healthcare entity to include the business type and the tax identification number of each; and |
16 | (6) An analysis of trends in horizontal and vertical consolidation, disaggregated by business |
17 | structure and provider type. |
18 | (c) The department of health may share information reported under this chapter with the |
19 | attorney general, other state agencies, and other state officials, to reduce or avoid duplication in |
20 | reporting requirements or to facilitate oversight or enforcement pursuant to the laws of the state, |
21 | provided that any tax ID numbers that are individual Social Security numbers may be shared with |
22 | the attorney general, other state agencies, or other state officials that agree to maintain the |
23 | confidentiality of such information. The department of health may, in consultation with the relevant |
24 | state agencies, merge similar reporting requirements where appropriate. |
25 | 23-107-5. Enforcement. |
26 | (a) Audit and inspection authority. The department of health is authorized to audit and |
27 | inspect the records of any healthcare entity that has failed to submit complete information pursuant |
28 | to this chapter or if the department of health has reason to question the accuracy or completeness |
29 | of the information submitted pursuant to this chapter. |
30 | (b) Random audits. The department of health shall conduct annual audits of a random |
31 | sample of healthcare entities to verify compliance with, accuracy and completeness of the reported |
32 | information pursuant to this chapter. |
33 | (c) Penalty for failure to report. If a healthcare entity fails to provide a complete report as |
34 | required under § 23-107-1, or submits a report containing false information, such entity shall be |
| LC004727 - Page 9 of 11 |
1 | subject to a civil penalty as follows: |
2 | (1) Healthcare entities consisting of independent healthcare providers or provider |
3 | organizations without any third-party ownership or control entities, with ten (10) or fewer |
4 | physicians or less than ten million dollars ($10,000,000) in annual revenue, the penalty shall not |
5 | exceed fifty thousand dollars ($50,000) for each report not provided or containing false |
6 | information. |
7 | (2) For all other healthcare entities, the penalty shall not exceed five hundred thousand |
8 | dollars ($500,000) for each report not provided or containing false information. |
9 | SECTION 3. This act shall take effect upon passage. |
======== | |
LC004727 | |
======== | |
| LC004727 - Page 10 of 11 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO HEALTH AND SAFETY -- RHODE ISLAND BAN ON THE CORPORATE | |
PRACTICE OF MEDICINE ACT | |
*** | |
1 | This act would establish the Rhode Island Ban on the Corporate Practice of Medicine Act, |
2 | and the Rhode Island transparency in ownership and control of healthcare facilities act. The act |
3 | would regulate the ownership of medical practices by unlicensed corporate and other business |
4 | entities and require reporting of ownership and control of healthcare facilities in the state. |
5 | This act would take effect upon passage. |
======== | |
LC004727 | |
======== | |
| LC004727 - Page 11 of 11 |